Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Lorlatinib surpasses crizotinib as first-line treatment for advanced ALK+ lung cancer Next Article
Sentinel-lymph-node biopsy has edge on lymphadenectomy in endometrial-cancer staging »
« Lorlatinib surpasses crizotinib as first-line treatment for advanced ALK+ lung cancer Next Article
Sentinel-lymph-node biopsy has edge on lymphadenectomy in endometrial-cancer staging »
Related Articles
January 14, 2022
Therapeutic approaches in heart failure with diabetes
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy